ADIPOR1P2

Across TCGA pan-cancer cohorts, ADIPOR1P2 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated ADIPOR1P2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ADIPOR1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ADIPOR1P2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and OV show a favorable association.

ACC, LGG, and CHOL are the cancer types where ADIPOR1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.076	0.414	.025	42	view →
LGG	OS	Tertile	All	0.664	0.831	.001	33	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	27	view →
UCEC	DFS	Tertile	All	0.836	0.913	.008	24	view →
KICH	OS	Tertile	II,III,IV	0.216	0.838	.010	18	view →
BLCA	OS	Tertile	IV	0.063	0.576	<.001	18	view →
LUAD	OS	Tertile	III,IV	0.270	0.572	.017	18	view →
READ	OS	Tertile	IV	0.439	0.824	.003	17	view →
PAAD	OS	Median	III,IV	0.629	1.000	.022	9	view →
SKCM	DFS	Tertile	II,III,IV	0.445	0.586	.032	6	view →
BRCA	OS	Tertile	III,IV	0.957	0.882	.031	6	view →
OV	OS	Median	IV	0.744	0.505	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

ADIPOR1P2–ACC (DFS)

Open the ACC breakdown →